NDC 50090-6348-01 - Valsartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6348
- Requested NDC
- 50090-6348-01
- Package NDCs from labels
- 50090-6348-0, 50090-6348-1, 50090-6348-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-10-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Valsartan - A-S Medication Solutions | A-S Medication Solutions | 2023-10-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6348-0 | Valsartan | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 50090-6348-1 | Valsartan | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6348 | VALSARTAN (VALSARTAN) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 2 package rows | 20231004_688b5c82-2eba-445c-869e-60609f5db86a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6348-0 | EA - Each | 50090-6348 | 3fdd390d-97da-453f-bac1-ed4f21cf6fa1 | 1 | 2023-03-13 |
| 50090-6348-1 | EA - Each | 50090-6348 | c7d673e6-6a96-47f0-b5c5-eb591005bdd6 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Birch | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d5431d62-fded-4cdc-81a1-5b5e3eb92873 | 2021-06-29 | Warnings | 15FIX9V2JP |
| No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Tawny | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 52c3378f-6b99-42fa-900e-8a693864c615 | 2021-06-29 | Warnings | 15FIX9V2JP |
| Valsartan | VALSARTAN | Proficient Rx LP | b58471fe-e2c6-4cc5-9d49-6a3111f6e002 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 349200 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 75b3f944-b4fc-40a5-a4e2-aec2fbab64b8 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a06ee3c1-bd0d-4dda-a453-1655eebffdae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 411caa05-5eff-4285-a940-7f6d2429ba81 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | e1f94546-c71c-4175-9384-20238181e05f | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 1f6ab5e0-8320-4489-bed2-8c90c534e5ae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d701c221-9f68-47ff-b766-2f4f1998649f | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 9c407dc7-fcde-4660-9a06-57bd8a6b867d | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | f07e8bb2-30ae-4337-ad60-84f55f2ff354 | 2019-10-08 | Warnings | 15FIX9V2JP |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | be008c6a-6036-4abf-a3fc-450465c88d55 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | ec24af8d-29a3-4217-8f06-ac217ea55b9e | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 6c363351-6596-42bf-83c9-041bf231b778 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Amneal Pharmaceuticals LLC | c9acbc95-3629-4276-842b-5c074844dba7 | 2019-02-02 | Boxed warning, Warnings, Adverse reactions | 80M03YXJ7I |
| CLE CCC Golden Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | b7a4847f-b84d-4f36-8787-104eccd838a0 | 2018-12-03 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | 229c20a3-6288-4ac3-9098-6d1622e906ab | 2018-11-29 | Warnings | 15FIX9V2JP |
| CLE CCC Warm Medium Light | TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE | KW ABSC, INC. | fc90fb8a-44b3-47cd-882e-94ed324ed389 | 2018-11-27 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.